Ontology highlight
ABSTRACT:
SUBMITTER: Zhang S
PROVIDER: S-EPMC9773544 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
Zhang Suli S Sun Qian Q Cai Feng F Li Hui H Zhou Yufu Y
Frontiers in oncology 20221208
Standard treatments for patients with metastatic non-small cell lung cancer (NSCLC) include palliative chemotherapy and radiotherapy, but with limited survival rates. With the development of improved immunotherapy and targeted therapy, NSCLC prognoses have significantly improved. In recent years, the concept of oligometastatic disease has been developed, with randomized trial data showing survival benefits from local ablation therapy (LAT) in patients with oligometastatic NSCLC (OM-NSCLC). LAT i ...[more]